The Centers for Disease Control and Prevention's vaccine advisory committee appears set to amend the childhood immunization ...
Pivotal Phase 3 randomized, double-blind, placebo-controlled study (n=106) met the primary endpoint (PUL v2.0) and the key secondary cardiac endpoint (LVEF), both achieving statistical significance ...
Virax Biolabs Group Limited ("Virax" or the "Company"), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, today highlighted key milestones, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback